Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.

J G Cleland, H J Dargie, S G Ball, G Gillen, G P Hodsman, J J Morton, B W East, I Robertson, I Ford, J I Robertson

Several studies have shown symptomatic and haemodynamic improvement after the introduction of angiotensin converting enzyme inhibitors in patients with heart failure treated with diuretics. The concomitant long term effects of the new orally effective long acting angiotensin converting enzyme inhibitor, enalapril, on symptoms, exercise performance, cardiac function, arrhythmias, hormones, electrolytes, body composition, and renal function have been further assessed in a placebo controlled double blind cross over trial with treatment periods of eight weeks. Twenty patients with New York Heart Association functional class II to IV heart failure who were clinically stable on digoxin and diuretic therapy were studied. Apart from the introduction of enalapril, regular treatment was not changed over the study period; no order or period effects were noted. Enalapril treatment significantly improved functional class, symptom score for breathlessness, and exercise tolerance. Systolic blood pressure was significantly lower on enalapril treatment. Echocardiographic assessment indicated a reduction in left ventricular dimensions and an improvement in systolic time intervals. In response to enalapril, the plasma concentration of angiotensin II was reduced and that of active renin rose; plasma concentrations of aldosterone, vasopressin, and noradrenaline fell. There were significant increases in serum potassium and serum magnesium on enalapril. Glomerular filtration rate measured both by isotopic techniques and by creatinine clearance declined on enalapril while serum urea and creatinine rose and effective renal plasma flow increased. Body weight and total body sodium were unchanged indicating that there was no overall diuresis. There was a statistically insignificant rise in total body potassium, though the increase was related directly to pretreatment plasma renin (r = 0.5). On enalapril the improvement in symptoms, exercise performance, fall in plasma noradrenaline, and rise in serum potassium coincided with a decline in the frequency of ventricular extrasystoles recorded during ambulatory monitoring. Adverse effects were few. In patients with heart failure, enalapril had a beneficial effect on symptoms and functional capacity. The decline in glomerular filtration rate on enalapril may not be beneficial in early heart failure.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: e1-e90 [Full Text]  
• Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53: 1343-1382 [Full Text]  
• 2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977-2016 [Full Text]  
• 2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W. (2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: e391-e479 [Full Text]  
• Developed in Collaboration With the American Colle, , Endorsed by the Heart Rhythm Society, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46: 1116-1143 [Full Text]  
• Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112: 1825-1852 [Full Text]  
• Abdulla, J., Abildstrom, S. Z., Christensen, E., Kober, L., Torp-Pedersen, C. (2004). A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction. Eur J Heart Fail 6: 927-935 [Abstract] [Full Text]  
• Brunner-La Rocca, H. P. (2003). Interaction of Angiotensin-Converting Enzyme Inhibition and Aspirin in Congestive Heart Failure: Long Controversy Finally Resolved?. Chest 124: 1192-1194 [Full Text]  
• Kittleson, M., Hurwitz, S., Shah, M. R., Nohria, A., Lewis, E., Givertz, M., Fang, J., Jarcho, J., Mudge, G., Stevenson, L. W. (2003). Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 41: 2029-2035 [Abstract] [Full Text]  
• (2001). Recommendations for exercise testing in chronic heart faliure patients. Eur Heart J 22: 37-45  
• Sigurdsson, A., Eriksson, S.V., Hall, C., Kahan, T., Swedberg, K. (2001). Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study. Eur J Heart Fail 3: 69-78 [Abstract] [Full Text]  
• Nanas, J. N., Alexopoulos, G., Anastasiou-Nana, M. I., Karidis, K., Tirologos, A., Zobolos, S., Pirgakis, V., Anthopoulos, L., Sideris, D., Stamatelopoulos, S. F., Moulopoulos, S. D., for the High Enalapril Dose Study Group, (2000). Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. J Am Coll Cardiol 36: 2090-2095 [Abstract] [Full Text]  
• Louch, W. E., Ferrier, G. R., Howlett, S. E. (2000). Losartan Improves Recovery of Contraction and Inhibits Transient Inward Current in a Cellular Model of Cardiac Ischemia and Reperfusion. J. Pharmacol. Exp. Ther. 295: 697-704 [Abstract] [Full Text]  
• Dutka, D. P., Puri, S., Strong, R., Cleland, J. G.F. (1999). Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction. Eur J Heart Fail 1: 371-377 [Abstract] [Full Text]  
• Brunner-La Rocca, H. P., Vaddadi, G., Esler, M. D. (1999). Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol 33: 1163-1173 [Abstract] [Full Text]  
• Eccles, M., Freemantle, N., Mason, J. (1998). North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ 316: 1369-1375 [Full Text]  
• Garg, R., Yusuf, S., the Collaborative Group on ACE Inhibitor Trials, , Bussmann, W. D., Sleight, P., Uprichard, A., Massie, B., McGrath, B., Nilsson, B., Pitt, B., Magnani, B., Maskin, C., Ambrosioni, E., Rucinska, E., Kleber, F. X., Jennings, G., Tognoni, G., Drexler, H., Cleland, J. G. F., Franciosa, J. A., Remes, J., Swedberg, K., Swedberg, K., Dickstein, K., Maass, L., Pfeffer, M., Creager, M. A., Gordon, M., Joy, M., Sharpe, N., Sleight, P., Desche, P., McGarry, R., Collins, R., Chrysant, S. G., Cicchetti, V., Bussmann, W. D. (1995). Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure. JAMA 273: 1450-1456 [Abstract]  
• Dargie, H J, McMurray, J J V (1994). Fortnightly Review: Diagnosis and management of heart failure. BMJ 308: 321-328 [Abstract] [Full Text]  
• Oster, J. R., Materson, B. J. (1992). Renal and Electrolyte Complications of Congestive Heart Failure and Effects of Therapy With Angiotensin-Converting Enzyme Inhibitors. Arch Intern Med 152: 704-710 [Abstract]  
• Kulick, D. L., Rahimtoola, S. H. (1991). Current Role of Digitalis Therapy in Patients With Congestive Heart Failure. JAMA 265: 2995-2997 [Abstract]  
• Deedwania, P. C. (1990). Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure. Arch Intern Med 150: 1798-1805 [Abstract]  
• Munger, M. A., Gardner, S. F., Jarvis, R. C. (1990). Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure. Journal of Pharmacy Practice 3: 318-331 [Abstract]  
• Marantz, P. R., Alderman, M. H., Tobin, J. N. (1988). Diagnostic Heterogeneity in Clinical Trials for Congestive Heart Failure. ANN INTERN MED 109: 55-61 [Abstract]  
• Mulrow, C. D., Mulrow, J. P., Linn, W. D., Aguilar, C., Ramirez, G. (1988). Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure: Implications of Randomized Trials. JAMA 259: 3422-3426 [Abstract]  
• PACKER, M., LEE, W. H., MEDINA, N., YUSHAK, M., KESSLER, P. D. (1987). Functional Renal Insufficiency During Long-Term Therapy with Captopril and Enalapril in Severe Chronic Heart Failure. ANN INTERN MED 106: 346-354 [Abstract]